21
Nov
2019
Applying Operational Excellence to Improve Injectable Pharmaceuticals Production
For the past few years, the injectable pharmaceuticals market has faced major challenges, reflected in ongoing shortages of critically important products (1). As governments cut healthcare spending to reduce costs (2), patients are demanding more personalized delivery methods such as auto-injectors (3) and regulators, sensitized by serious compliance problems in the past (4), are increasing scrutiny of aseptic filling and manufacturing operations (5). Adapting to these changes, while improving product quality, requires manufacturing processes that are as efficient, flexible, and compliant as possible. Read more insights in this article.
